Surgery Partners director Teresa DeLuca buys $161,212 in stock

Director Teresa DeLuca of Surgery Partners Inc. (SGRY) acquired 11,250 shares of the company's common stock on August 18, 2026, for a total of $161,212. The transaction took place at a price of $14.33 per share, resulting in Ms. DeLuca owning a total of 68,093 shares. The stock, currently trading at $13.94, has seen a 7.3% decline over the past week.

The amended Form 4 filing, dated August 20, 2026, corrected an earlier report of a purchase of 10,000 shares at $14.35 per share. This move comes as Surgery Partners reports a wider-than-expected loss in its second-quarter 2026 financial results, with adjusted earnings at negative $0.12 per share, while analysts had expected a profit of $0.06 per share.

Despite the earnings miss, the company reported revenue of $848.9 million, exceeding the forecast of $830.05 million. The company is undergoing a significant portfolio shift, primarily through the planned sale of two Idaho Falls community hospitals, expected to generate around $795 million. Analysts have reiterated a Buy rating for Surgery Partners with a $24 price target, reflecting confidence in the company's strategic moves.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.